Medication info
Amendin Tablet (Memantine Hydrochloride)

Amendin Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Mirae Bio Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200600463 · Notified 2006.01.04 · Insurance code 657500710

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is able to check the patient's medication use regularly. Diagnosis should be made in accordance with currently accepted guidelines. The patient's clinical benefit and tolerability of treatment should be reassessed regularly. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily (10mg twice daily). Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to these patients.

Ingredients

Manufacturer
Mirae Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps alleviate memory decline and cognitive dysfunction, improving the quality of daily life. When taken continuously, it can slow the progression of symptoms.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is able to check the patient's medication use regularly. Diagnosis should be made in accordance with currently accepted guidelines. The patient's clinical benefit and tolerability of treatment should be reassessed regularly. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily (10mg twice daily). Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to these patients.

Precautions

This medication should not be used by patients who are allergic to its components. It should also not be administered to patients with very poor liver function or severely impaired kidney function. Patients with epilepsy or those who have experienced seizures in the past, as well as those prone to seizures, should use this medication with caution. Additionally, co-administration with NMDA antagonists such as amantadine, ketamine, and dextromethorphan may exacerbate side effects, so they should not be combined. Caution is also necessary if factors that change urine acidity (pH) or excessive intake of alkaline beverages are present. There is no established safety in patients with recent myocardial infarction, heart failure, or uncontrolled hypertension, so administration should be done carefully. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if symptoms worsen, patients should consult their physicians. Rare reports of mental confusion, hallucinations, and psychotic symptoms have been noted, so if these symptoms occur, immediate notification to healthcare professionals is required. This medication can interact with other drugs, particularly NMDA antagonists, antipsychotics, muscle relaxants, and anticoagulants, so caution is necessary when taken together. Women who are pregnant or may become pregnant should consult a physician before using this medication, and it is advisable to stop breastfeeding if nursing. It is preferable not to use this medication in children or adolescents under 18 years of age, as safety and efficacy have not been established. In cases of overdose, central nervous system symptoms and gastrointestinal symptoms may occur, and immediate hospital visit for appropriate treatment is necessary. Caution should be exercised when driving or operating machinery while taking this medication, especially for Alzheimer's patients, who should avoid these activities for safety. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 22 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • asthenia
  • diarrhea
  • agitation
  • aggression
  • stupor
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucinations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, and it is safest to keep it at room temperature between 1°C and 30°C. This will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.